Gelonghui July 10?Hainan Marine Medicine (000566.SZ) is expected to be released.2020One and a half yearsBelong to a listed companyNet profit of shareholders4000Ten thousand yuan-6000Ten thousand yuan, down from the same period last year26%-51%.The main reasons for the performance changes are as follows:

one、2020In the first quarter of 2000, it was affected by the epidemic of COVID-19.Cause the company and customers to resume work and delay production.Late; the prices of raw materials and intermediates for the production of the company have risen sharply, resulting in a rise in production costs; provided by hospitals across the countryDiagnosis and treatment services and patient visits are affected to varying degrees, and the terminal demand for drugs has dropped seriously, resulting in the company.ProductOperating income compared with the same period last yearDrop.2020In the second quarter of 2000, with the domestic epidemicGradually get effective controlThe terminal demand for diagnosis and treatment services and drugs in medical institutions gradually recovered, but it was not as expected.CompanyTake multiple measures at the same timeAs a wholeThe operating situation has improved greatly compared with the first quarter.

Combining the above factors, the company2020YearHalf a yearThe production and operation of degree is affected byDefinitelyInfluence, so as to reportThe net profit attributable to the shareholders of the listed company is higher than that of the same period last year.Have somethingDown.

two、During the reporting period, the company held China Antibody Pharmaceutical Co., Ltd., which is listed on the main board of the Stock Exchange of Hong Kong.Company stock152040200StockThe profit and loss affected by the changes in the fair value of the above equity is expected to be about11223.91Ten thousand yuan.

three、It is estimated that the impact of the company's non-recurring profit and loss on net profit during the reporting period is aboutfifteeneight hundred and seventy fourTen thousand yuan.